Clinical trial
Chemotherapy-induced Circadian Rhythm Disruption: Investigation Using Biomarker
NCT04364347 is registered in ClinicalTrials.gov with Seoul National University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Chemotherapy-induced Circadian Rhythm Disruption: Investigation Using Biomarker
- Lead sponsor
- Seoul National University Hospital
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- December 14, 2019
- Completion date
- February 28, 2023
- Enrollment
- 27 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.